Inaktiver Wert

20/20 GeneSystems Inc. Aktie

Aktien

Dauer

Zeitraum

Stil

20/20 GeneSystems Inc. announced that it expects to receive $4.999995 million in funding	15.08.22
20/20 GeneSystems, Inc. Launches First Accelerator Facility for Innovative Clinical Lab Tests	28.09.21
20/20 GeneSystems, Inc. announced that it has received $2 million in funding	04.02.16
20/20 GeneSystems, Inc. announced that it expects to receive $3 million in funding.	28.01.16
20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.	14.01.16

Manager	Titel	Alter	Seit
Jonathan Cohen CEO	Chief Executive Officer	-	01.01.08
Nora Li PRN	Corporate Officer/Principal	-	-

Aufsichtsräte	Titel	Alter	Seit
Richard Cohen BRD	Director/Board Member	73	01.01.16
Jonathan Cohen CEO	Chief Executive Officer	-	01.01.08
John Compton BRD	Director/Board Member	-	-

Sektor